|
Consolidated Balance Sheets (USD $)
|
Dec. 31, 2013
|
Dec. 31, 2012
|
| Current assets |
|
|
| Cash and cash equivalents |
$ 4,136,803 |
$ 17,782 |
| Taxes and other receivables |
11,062 |
45,499 |
| Prepaid expenses |
170,883 |
28,778 |
| Deferred costs |
|
90,771 |
| Assets, total |
4,318,748 |
182,830 |
| Current liabilities |
|
|
| Accounts payable and accrued liabilities |
140,457 |
677,615 |
| Related party payables |
109,030 |
447,777 |
| Current liabilities, total |
249,487 |
1,125,392 |
| Loan payable to Valent |
272,372 |
264,352 |
| Stock option liability |
212,561 |
|
| Derivative liability |
4,402,306 |
121,000 |
| Liabilities, total |
5,136,726 |
1,510,744 |
| Stockholders' Deficiency |
|
|
| Preferred stock Authorized 5,000,000 shares, $0.001 par value 1 share outstanding at December 31, 2013 (December 31, 2012 - nil) |
|
|
| Common stock Authorized 200,000,000 shares, $0.001 par value 31,534,819 Issued at December 31, 2013 (December 31, 2012 - 13,050,000) |
31,535 |
13,050 |
| Additional paid-in capital |
8,791,715 |
2,326,885 |
| Warrants |
6,202,100 |
153,106 |
| Deficit accumulated during the development stage |
(15,864,506) |
(3,842,133) |
| Accumulated other comprehensive income |
21,178 |
21,178 |
| Stockholders' equity, total |
(817,978) |
(1,327,914) |
| Liabilities and equity, total |
$ 4,318,748 |
$ 182,830 |